Approaching GOIS - Seventeenth Session

Approaching GOIS - Seventeenth Session

by Site Admin -
Number of replies: 0

 

                       Global Oncology University ( GO-U)

Approaching “Global Oncology-Implementing Science” GOIS courses    

17th session Wednesday Feb 21 , 2024, at 4.00-5.30 pm GMT

-----------------------------------   

Approaching “Global  Oncology-Implementing Science GOIS” Course program

The Global Oncology University (GO-U)

 Session 17th: Wednesday Feb.21, 2024 at 4.00 -5.30 PM GMT 

       Improving access to radiotherapy in LMICs through a collaborative initiative to reduce technology downtime  by:  

       Taofeeq A Ige, Alexander Jenkins, Manjit Dosanjh, Donna O’Brien, David Pistenmaa and C Norman Coleman  

 

       Solar-powered radiotherapy  ( By Ralf Muller-Polyzou and Holger Wirtz, Germany   

( Reference: Chapter 36, Approaching Global Oncology)

 

       Electronic Brachytherapy: By Prof. Ahmed Elzawawy 

********************************************************************

Links:  https://icedoc.website/cms/mod/zoom/view.php?id=34  

&

Join Zoom Meeting

https://us06web.zoom.us/j/86092740976?pwd=DLE8wWe1Zr75HqWzijFwCaavMG6lB4.1

Meeting ID: 860 9274 0976  Passcode: 744377

 

 

All your feedback and comments will be directed to the distinguished experts and co-leaders of GOIS

  Distinguished Scientific Experts of the 17th  session:         

a

Prof. Eduardo L. Cazap  MD, PhD, FASCO, Argentina , President & Founder -Latin-American & Caribbean Society of Medical Oncology (SLACOM) Co-Chair, Network of Latin American Cancer Institutes (RINC) .Past President - Union for International Cancer Control (UICC)

==================================

a

Professor David Kerr CBE MD PhD DSc FRCP FRCGP FACP FESMO FMedSci , UK : David contributes to Oxford as Professor of Cancer Medicine, where he has worked with colleagues to build a new Institute for Cancer Medicine and Cancer Hospital.  Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, Co-founder, GO-U.  ==================================

a 

Professor Karol Sikora, MA, MB BChir, PhD, MD, FRCR, FRCP, FFPM,  UK , Consultant Oncologist, is the Medical Director of Cancer Partners International. He was the Founding Dean and now Professor of Medicine at Britain’s first independent Medical School at the University of Buckingham and a Fellow of Corpus Christi College, Cambridge. He was Professor and Chairman of the Department of Cancer Medicine at Imperial College School of Medicine and is still honorary Consultant Oncologist at Hammersmith Hospital, London.  He was seconded to be Director of the WHO Cancer Programme in 2000. Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, Co-founder, GO-U.     

=======

a

Prof. Luca Incrocci, Netherlands, MD PhD

Professor of Genito-Urinary Radiotherapy, Erasmus MC Cancer Institute Department of Radiation Oncology, Rotterdam, The Netherlands and is actively involved in providing education and improving radiation therapy access in African countries. He recently launched his foundation ( www.LucaIncrocciFoundation.org ) to improve cancer care in Ethiopia.
Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program.

===========================

a

 Prof. Ahmed Elzawawy, MD, PhD, Founding Chair, win-win Scientific initiative & Co-founder & Chair, Board of Directors, GO-U & Global Oncology-Implementing Science Courses and program & ounding President, ICEDOC & Past President, AORTIC & Prof. Clinical Oncology, Suez Canal University &Chair. Clinical and Radiation Oncology Center , Port Said, Egypt.    

==================================

a

Prof. Wilfred Ngwa, PhD, Dana-Farber/Harvard Cancer Center, University of Massachusetts Lowell, and Johns Hopkins University, USA. He is a distinguished professor of global public health, and distinguished professor of public health. He is founding Director of the Global Health Catalyst launched at the Harvard Radcliffe Institute in 2015 He currently chairs the Africa Health and Infrastructure Committee advising the USA government on Global Health.  He is a co-founder (with Prof Ahmed Elzawawy and distinguished faculty) of Global Oncology University.  Founder Director, GHC& Co-founder, GO-U.  Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, GO-U

==================================

a

 Prof Cristina Stefan is a professor in medicine and global health, currently the President and CEO of the Medical Education Research and Innovation, adjunct professor at SingHealth Duke NUS  Singapore and UMF University, Main, USA. PhD in medical education, MBA , France, MSc , Pediatrics and Oncology , South Africa, MSc cancer epidemiology , UK.

She was past President , AORTIC , She was voted as the most influential African woman in business and government (medicine) in 2016 , among the top 100 Women Leaders in Healthcare in Asia, in 2020. In 2022, she received IARC the (International Agency for Research in Cancer) award for women in cancer research.

A  co-leader and distinguished faculty , The Global Oncology-implementing Science Program ( GOIS) ==================================

a

 Prof. Twalib A. Ngoma  , Prof. Clinical Oncology ,  Research Chair Holder Muhimbili University of Health and Allied Sciences  MUHAS ,  Dar es Salaam, Tanzania. Co-Leader, The win-win initiative and Co-Founder, Global Oncology University GO-U    

================================== 

 

a

-       Dr. Mrs. Beatrice Wiafe Addai, MD, PhD,
Consultant Breast Surgeon, C.E.O., Peace and Love Hospitals, Ghana
President and Founder, Breast Care International, Fmr Member, Ethics committee - IARC, Chairperson, Ghana Cancer Board, Medical Advisory Board Member, Direct Relief, Member, UICC & a Leader , Win-Win international Scientific Initiative

==================================    

a

Prof. Bashkim Ziberi . 

Department of Physics, University of Tetova, A leader and distinguished faculty The win-win international scientific initiative and Co-Director ,The Global Oncology-Implementing Science GOIS, GO-U  

===================================

a

Prof Abdelhamid H. Elgazzar , He Is board certified by the American Board of Anatomical and Clinical Pathology as well as by the American Board of Nuclear Medicine, worked as faculty staff at the University of Cincinnati School of Medicine, the Mount Sinai School of Medicine, and as a chief of Nuclear Medicine at Tufts, Boston. USA. He Is currently a professor and chairman of the Nuclear Medicine Department at Kuwait University. Has received 14 awards from several international professional organizations. He edited 10 textbooks and six book chapters including Chapters Nuclear Oncology &  Basis of Therapeutic Nuclear Medicine in   Synopsis of Pathophysiology in Nuclear Medicine”  Ed. Abdelhamid H. Elgazzar , Springer  https://doi.org/10.1007/978-3-031-20646-7    He is a chief advisor, and leader , Nuclear Medicine , Nuclear Medicine Oncology and combined therapy, ICEDOC & The win-win international Scientific Initiative  & the GOIS, GO-U

===================================

 

a

Dr. Taofeeq Abdallah IGE was a Consultant Physicist and Abuja , Nigeria. and a Visiting Senior Lecturer as well as an External Examiner to a couple of University Post-Graduate programmes in Medical Physics in the Country and the Region & Faculty of Radiology of both West African College of Surgeons (WACS , Past President of the Federation of the African Medical Physics Organization (FAMPO.)He also a national and regional counterpart to the International Atomic Energy Agency (IAEA) projects . He serves as committee member of the IOMP  and also the Health Technology Task Group of the International Union of Physical and Engineering Sciences in Medicine  and a leader in the win-win International Scientific Initiative

==================================   

 

a

Dipl.-Ing. (FH) Holger Wirtz                                                                                          

FH Aachen, Abt. Jülich ; engineering, Biomedical-engineering, radio-physics, Germany ,  he served in  University-Hospital Essen: clinical radiophysics and at present in MVZ Strahlentherapie-Singen-Friedrichshafen GmbH , Germany ,  and he is medical-product consultant ,ADAC Laboratories, PHILIPS HealthCare, ELEKTA.  Some oh his main scientific works,  “Emerging Technologies for Improving Access to Radiation Therapy and solar powered Radiotherapy”  

===========================================


i.V. Dr. Ralf Müller-Polyzou, Head of health care and industry business , 
LAP GmbH Laser Applikationen / Zeppelinstr. 23 / 21337 Lüneburg / Germany. One of his main interests and experiences is Solar- Powered Radiotherapy as win-win opportunity to increase approaches to global oncology.

Further reading:  

1.Chapter 16 , 21 and 36 in  “ Approaching Global Oncology. The win-win model” https://iopscience.iop.org/book/978-0-7503-3075-6   2.  The Win-Win Initiative.  www.icedoc.org/winwin.htm   and www.icedoc.net/winwin.htm    3. Elzawawy A. (2012). Science and Affordability of Cancer Drugs and Radiotherapy in the World - Win-Win Scenarios.  In: Advances in Cancer Management, Ravinder Mohan (Ed.), InTech, Free access and download:  https://www.intechopen.com/chapters/26808

 ======================

-How to join all sessions (It is for all GOIS sessions): please , Click on  & register and Login in , Create an account –if you haven’t- & fill the form,

https://icedoc.website/cms/mod/zoom/view.php?id=34     

----------------------------

Join Zoom Meeting to this 17th session ( 10 minutes before the session)

https://us06web.zoom.us/j/86092740976?pwd=DLE8wWe1Zr75HqWzijFwCaavMG6lB4.1

Meeting ID: 860 9274 0976  Passcode: 744377

=======================